Showing results (21-30 of 118) with videos related to
Sort By:
Pageof 12
Human Vaccines & Immunotherapeutics|May 3, 2014
The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countriesDaniel M Musher, Maria C Rodriguez-BarradasClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumoniaDaniel M Musher, Roberto Montoya, Anna WanahitaPneumonia (Nathan Qld.)|September 24, 2022
The remarkable history of pneumococcal vaccination: an ongoing challengeDaniel M Musher, Ronald Anderson, Charles FeldmanAvicenna Journal of Medicine|February 1, 2021
Impact of a division-wide bundle on hospital-acquired Clostridioides difficile cases, antibiotic days of therapy, testing appropriateness, and associated financial costsElizabeth Wenqian Wang, Ashlee Weekley, Jennifer McCarty, et al.Open Forum Infectious Diseases|April 15, 2021
Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus InfluenzaSaeed Shoar, Fernando H Centeno, Daniel M MusherOpen Forum Infectious Diseases|June 30, 2021
Erratum to: Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus influenzaeSaeed Shoar, Fernando H Centeno, Daniel M MusherClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
Long-term survival following pneumococcal pneumoniaBarcleigh Sandvall, Adriana M Rueda, Daniel M MusherClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficileAnna Wanahita, Elizabeth A Goldsmith, Daniel M MusherThe Lancet. Infectious Diseases|August 27, 2005
Treatment of Clostridium difficile-associated disease: old therapies and new strategiesSaima Aslam, Richard J Hamill, Daniel M MusherScandinavian Journal of Infectious Diseases|June 7, 2012
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycinPraveena Marconescu, Edward A Graviss, Daniel M MusherPageof 12